Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.55), $0.23 better than the analyst estimate of ($1.78). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $9.97 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.